Field-Based Oncology & Haematology MSL | Scientific Partner

Ipsen Pharma SAS; Greater London; Hybrid; GBP 70,000 - 90,000; Full time

Job summary

Ipsen Ltd in the United Kingdom is seeking an experienced Medical Science Liaison (MSL) for Oncology & Haematology to join our Field-Based Oncology Medical Affairs team. You will work across the UK delivering high-quality scientific engagement with healthcare professionals and key opinion leaders.

The successful candidate will support Ipsen's medical strategy, collaborate across Medical Affairs, Market Access, and Clinical Development, and contribute to evidence generation initiatives.

Qualifications

• Minimum experience as an MSL in the pharmaceutical industry.
• Strong capability to engage and communicate with healthcare professionals.
• ABPI Code knowledge or understanding is preferred.

Responsibilities

• Build and maintain scientific relationships with healthcare professionals and key opinion leaders.
• Deliver high-quality, compliant scientific exchanges on Ipsen's oncology portfolio.
• Gather, analyse, and communicate medical insights to inform strategy and evidence generation.
• Support medical education activities, advisory boards, and congresses.
• Contribute to investigator-initiated studies and real-world evidence projects.
• Act as a scientific resource for external stakeholders and internal teams.

Skills

MSL experience

Medical Affairs

Excellent communication

Relationship building

Scientific presentation

Education

Life Sciences/Pharmacy/Medicine degree

Job description

Ipsen Ltd in the United Kingdom is seeking an experienced Medical Science Liaison (MSL) for Oncology & Haematology to join our Field-Based Oncology Medical Affairs team. You will work across the UK delivering high-quality scientific engagement with healthcare professionals and key opinion leaders.

The successful candidate will support Ipsen's medical strategy, collaborate across Medical Affairs, Market Access, and Clinical Development, and contribute to evidence generation initiatives.